Pearson, Ewan

Professor of Diabetic Medicine, Professor

  • 7777 Citations
  • 41 h-Index
19992024
If you made any changes in Pure these will be visible here soon.

Personal profile

Biography

Ewan Pearson is Professor of Diabetic Medicine at the University of Dundee, Visiting Professor at the University of Edinburgh, and Honorary Consultant in Diabetes and Endocrinology at Ninewells Hospital and Medical School in Dundee.   In the School of Medicine, he is the Head of Division, Population Health & Genomics, and the Director of the Dundee Clinical Academic Track. 

Professor Pearson obtained his medical degree from the University of Cambridge School of Clinical Medicine, UK.  He undertook a Wellcome Trust Clinical Training fellowship with Prof Andrew Hattersley at the University of Exeter Medical School, UK and completed his PhD in the physiology and treatment of monogenic diabetes. He then moved to Dundee where he was supported by a Chief Scientist Office Clinician Scientisit fellowship and, more recently, by a Wellcome Trust Investigator Award.  Over the last ten years in Dundee his research interests have been in the phenotypic and genotypic determinants of drug response in diabetes, and in stratified approaches to the management of diabetes.  He leads the IMI-DIRECT project on stratification in type 2 diabetes and is strand 2 lead on the ABPI-MRC funded MASTERMIND project.  Ewan has been awarded the Royal College of Physicians of Edinburgh Croom Lecture, an EASD Rising Star award, the Diabetes UK RD Lawrence Lecture and the EASD Minkowski Award for his work in these areas.

 

Education/Academic qualification

Doctor of Medicine, Peninsula Medical School

Master of Arts, University of Cambridge

Bachelor of Medicine, University of Cambridge

Bachelor of Arts, University of Cambridge

External positions

Visiting Professor, University of Edinburgh

Fingerprint Dive into the research topics where Ewan Pearson is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 29 Similar Profiles
Type 2 Diabetes Mellitus Medicine & Life Sciences
Metformin Medicine & Life Sciences
Hepatocyte Nuclear Factor 1 Medicine & Life Sciences
Insulin Medicine & Life Sciences
Mutation Medicine & Life Sciences
Pharmacogenetics Medicine & Life Sciences
Genes Medicine & Life Sciences
Therapeutics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2013 2024

Research Output 1999 2019

4th ESPT Conference: pharmacogenomics and personalized medicine - research progress and clinical implementation

Sipeky, C., Llerena, A., Manolopoulos, V. G., Pearson, E., Mlakar, V., Gozzo, L., Simmaco, M., Marchetti, P., Re, M. D., Stankovic, S., Meyer, U., Cascorbi, I., Ingelman-Sundberg, M., Suarez-Kurtz, G., Marc, J., Katsila, T., Paulmichl, M., Nofziger, C., Ansari, M., Drago, F. & 1 others, van Schaik, R. H., Oct 2019, In : Pharmacogenomics. 20, 15, p. 1063-1069 7 p.

Research output: Contribution to journalArticle

Precision Medicine
Pharmacogenetics
Research
Sicily
Italy
5 Citations (Scopus)
215 Downloads (Pure)

A Type 1 Diabetes Genetic Risk Score Can Identify Patients With GAD65 Autoantibody-Positive Type 2 Diabetes Who Rapidly Progress to Insulin Therapy

Grubb, A. L., McDonald, T. J., Rutters, F., Donnelly, L., Hattersley, A. T., Oram, R. A., Palmer, C., van der Heijden, A. A., Carr, F., Elders, P. J. M., Weedon, M., Slieker, R. C., 't Hart, L. M., Pearson, E., Shields, B. M. & Jones, A. G., 1 Feb 2019, In : Diabetes Care. 42, 2, p. 208-214 7 p.

Research output: Contribution to journalArticle

Open Access
File
Type 1 Diabetes Mellitus
Autoantibodies
Type 2 Diabetes Mellitus
Insulin
Therapeutics
19 Downloads (Pure)

Development and validation of multivariable clinical diagnostic models to identify type 1 diabetes requiring rapid insulin therapy in adults aged 18-50 years

Lynam, A., McDonald, T., Hill, A., Dennis, J., Oram, R., Pearson, E., Weedon, M., Hattersley, A., Owen, K., Shields, B. & Jones, A., 26 Sep 2019, In : BMJ Open. 9, 9, p. 1-10 10 p., e031586.

Research output: Contribution to journalArticle

Open Access
File
Type 1 Diabetes Mellitus
Insulin
Area Under Curve
Therapeutics
ROC Curve
1 Citation (Scopus)
33 Downloads (Pure)

Diabetes: Is there a future for Pharmacogenomics guided treatment?

Pearson, E., Aug 2019, In : Clinical Pharmacology & Therapeutics. 106, 2, p. 329-337 9 p.

Research output: Contribution to journalArticle

Open Access
File
Pharmacogenetics
Clinical Decision Support Systems
Thiazolidinediones
Metformin
Hyperglycemia

Activities 2006 2017

  • 3 Invited talk

ESPT meeting Catania, Sicilly

Ewan Pearson (Speaker)
4 Oct 2017

Activity: Talk or presentation typesInvited talk

EASD Genetics Study Group, Leiden

Ewan Pearson (Speaker)
12 May 2017

Activity: Talk or presentation typesInvited talk

The Croom Lecture - Royal College of Physicians of Edinburgh

Ewan R. Pearson (Speaker)
2006

Activity: Talk or presentation typesInvited talk

Thesis

Clinical and genetic determinants of diabetic retinopathy

Author: Liu, Y., 2014

Supervisor: Palmer, C. (Supervisor) & Pearson, E. (Supervisor)

Student thesis: Doctoral ThesisDoctor of Philosophy

File

Genetic and non-genetic determinants of drug response in type 2 diabetes

Author: Dawed, A. Y., 2017

Supervisor: Pearson, E. (Supervisor) & Zhou, K. (Supervisor)

Student thesis: Doctoral ThesisDoctor of Medicine

Genetic Epidemiology Studies of aspects of Diabetic Complications

Author: Deshmukh, H., 2014

Supervisor: Colhoun, H. (Supervisor) & Pearson, E. (Supervisor)

Student thesis: Doctoral ThesisDoctor of Philosophy

File

Pharmacological modulation of insulin resistance - benefits and harms

Author: Vella, S., 2013

Supervisor: Petrie, J. (Supervisor), Lang, C. (Supervisor) & Pearson, E. (Supervisor)

Student thesis: Doctoral ThesisDoctor of Medicine

File